Hec Cj Pharm

In 2023, Hec Cj Pharm reported total carbon emissions of approximately 68.8 million tonnes CO2e, with Scope 1 emissions at about 2,000 tonnes CO2e and Scope 2 emissions at around 68.8 million tonnes CO2e. This marks a significant increase from previous years, where emissions were approximately 62.2 million tonnes CO2e in 2022 and 63.7 million tonnes CO2e in 2021. The company's emissions have shown a trend of fluctuation over the years, with total emissions recorded at about 42.5 million tonnes CO2e in 2020 and approximately 34.6 million tonnes CO2e in 2019. Notably, the Scope 1 emissions have remained relatively low compared to Scope 2, indicating that the majority of their emissions stem from indirect sources, likely related to energy consumption. Hec Cj Pharm has not publicly disclosed specific reduction targets or initiatives aimed at decreasing their carbon footprint. Their participation in climate reporting platforms, such as CDP, suggests a commitment to transparency, although their scores have not been made available. The absence of defined reduction targets indicates that while the company is aware of its emissions, it may still be in the early stages of developing a comprehensive climate strategy. Overall, Hec Cj Pharm's emissions data reflects the challenges faced by the pharmaceutical industry in managing carbon outputs, particularly in the context of increasing operational demands and energy use.